Growth Metrics

Silence Therapeutics (SLN) Return on Assets (2024 - 2025)

Silence Therapeutics' Return on Assets history spans 2 years, with the latest figure at 0.59% for Q4 2025.

  • For Q4 2025, Return on Assets fell 33.0% year-over-year to 0.59%; the TTM value through Dec 2025 reached 0.59%, down 33.0%, while the annual FY2025 figure was 0.41%, 13.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.59% at Silence Therapeutics, down from 0.39% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.01% in Q1 2024 and bottomed at 0.59% in Q4 2025.